Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Haim Erder

Showing results (1-10 of 61) with videos related to

Pageof 7
Sort By:
Clinical Drug Investigation|December 21, 2014
Interpreting the results of a retrospective comparison of test and reference treatments in a randomized clinical trial settingMoshe Fridman, M Haim Erder
Current Medical Research and Opinion|March 12, 2008
A Markov cost-utility analysis of escitalopram and duloxetine for the treatment of major depressive disorderEdward P Armstrong, Daniel C Malone, M Haim Erder
Current Medical Research and Opinion|February 10, 2007
Cost-utility comparison of escitalopram and sertraline in the treatment of major depressive disorderEdward P Armstrong, Grant H Skrepnek, M Haim Erder
Current Medical Research and Opinion|February 10, 2007
Escitalopram versus sertraline in the treatment of major depressive disorder: a randomized clinical trialDaniel Ventura, Edward P Armstrong, Grant H Skrepnek, et al.
Health Economics|September 14, 2016
Evaluating Matching-Adjusted Indirect Comparisons in Practice: A Case Study of Patients with Attention-Deficit/Hyperactivity DisorderJason Shafrin, Anshu Shrestha, Amitabh Chandra, et al.
Drugs in R&D|November 26, 2013
Concomitant pharmacotherapy of psychotropic medications in EU children and adolescents with attention-deficit/hyperactivity disorderVanja Sikirica, Moshe Fridman, Amanda Bruno, et al.
Current Medical Research and Opinion|August 5, 2008
Comparison of escitalopram versus citalopram for the treatment of major depressive disorder in a geriatric populationEric Wu, Paul E Greenberg, Elaine Yang, et al.
Health and Quality of Life Outcomes|August 23, 2015
Evaluating functional outcomes in adolescents with attention-deficit/hyperactivity disorder: development and initial testing of a self-report instrumentAsha Hareendran, Juliana Setyawan, Robin Pokrzywinski, et al.
Breast Cancer Research : BCR|August 21, 2003
First-cycle absolute neutrophil count can be used to improve chemotherapy-dose delivery and reduce the risk of febrile neutropenia in patients receiving adjuvant therapy: a validation studyEdgardo Rivera, M Haim Erder, Moshe Fridman, et al.
Cancer|July 2, 2003
The relationship between psychologic distress and cancer-related fatigueN Simon Tchekmedyian, Joel Kallich, Anne McDermott, et al.
Pageof 7

Showing results (1-10 of 61) with videos related to

Sort By:
Pageof 7
Clinical Drug Investigation|December 21, 2014
Interpreting the results of a retrospective comparison of test and reference treatments in a randomized clinical trial settingMoshe Fridman, M Haim Erder
Current Medical Research and Opinion|March 12, 2008
A Markov cost-utility analysis of escitalopram and duloxetine for the treatment of major depressive disorderEdward P Armstrong, Daniel C Malone, M Haim Erder
Current Medical Research and Opinion|February 10, 2007
Cost-utility comparison of escitalopram and sertraline in the treatment of major depressive disorderEdward P Armstrong, Grant H Skrepnek, M Haim Erder
Current Medical Research and Opinion|February 10, 2007
Escitalopram versus sertraline in the treatment of major depressive disorder: a randomized clinical trialDaniel Ventura, Edward P Armstrong, Grant H Skrepnek, et al.
Health Economics|September 14, 2016
Evaluating Matching-Adjusted Indirect Comparisons in Practice: A Case Study of Patients with Attention-Deficit/Hyperactivity DisorderJason Shafrin, Anshu Shrestha, Amitabh Chandra, et al.
Drugs in R&D|November 26, 2013
Concomitant pharmacotherapy of psychotropic medications in EU children and adolescents with attention-deficit/hyperactivity disorderVanja Sikirica, Moshe Fridman, Amanda Bruno, et al.
Current Medical Research and Opinion|August 5, 2008
Comparison of escitalopram versus citalopram for the treatment of major depressive disorder in a geriatric populationEric Wu, Paul E Greenberg, Elaine Yang, et al.
Health and Quality of Life Outcomes|August 23, 2015
Evaluating functional outcomes in adolescents with attention-deficit/hyperactivity disorder: development and initial testing of a self-report instrumentAsha Hareendran, Juliana Setyawan, Robin Pokrzywinski, et al.
Breast Cancer Research : BCR|August 21, 2003
First-cycle absolute neutrophil count can be used to improve chemotherapy-dose delivery and reduce the risk of febrile neutropenia in patients receiving adjuvant therapy: a validation studyEdgardo Rivera, M Haim Erder, Moshe Fridman, et al.
Cancer|July 2, 2003
The relationship between psychologic distress and cancer-related fatigueN Simon Tchekmedyian, Joel Kallich, Anne McDermott, et al.
Pageof 7